Craig Landry

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy

E. Heath, J. Fontana, U. Vaishampayan, 2017, Journal of Immunotherapy for Cancer.